呼吸道标本中曲霉侧流试验的诊断准确性:多中心研究
该多中心研究评估了曲霉特异性即时检测LFA-IMMY™在支气管肺泡液和痰液中检测曲霉的准确性,并探讨与其他真菌病原体的交叉反应。结果显示对培养和镜检阳性样本的灵敏度为92%,特异性为91%,但存在与非曲霉病原体的交叉反应。LFA-IMMY是检测呼吸道样本中曲霉的可靠诊断工具。
要点
- LFA-IMMY在呼吸道标本中检测曲霉的灵敏度为92%,特异性为91%。
- 该试验存在与非曲霉病原体的交叉反应。
- LFA-IMMY可作为检测呼吸道样本中曲霉的可靠诊断工具。
核心结论
- LFA-IMMY是检测呼吸道样本中曲霉的可靠诊断工具。
研究设计与样本
- 多中心研究,纳入非选择性患者的呼吸道标本398份(来自390例患者)。
主要发现
- 对曲霉培养和镜检阳性样本,灵敏度(48/52)为92%(95% CI 8.0%-9.7%),特异性(44/48)为91%(95% CI 7.9%-9.7%)。
- 观察到与非曲霉病原体的交叉反应。
临床怎么用
- LFA-IMMY可用于呼吸道标本中曲霉的检测。
- 需注意与其他真菌病原体的交叉反应可能影响结果解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Proper diagnosis of invasive aspergillosis is challenging because conventional methods lack sensitivity and are complicated by time-consuming incubation processes. To meet the requirement for early diagnosis the new Aspergillus-specific point-of-care test LFA-IMMY™ was evaluated with respect to the ability to accurately detect Aspergillus in bronchoalveolar fluids and sputa, and to clarify the potential of cross-reactivity with other fungal pathogens. METHODS: Respiratory specimens (n = 398) from non-selected patients (n = 390) underwent either fungal microscopy, culture or both before Aspergillus lateral flow assay (LFA-IMMY) testing. RESULTS: For Aspergillus culture- and microscopy-positive samples, sensitivity (48/52) and specificity (44/48) were 92% (95% CI 8.0%-9.7%) and 91% (95% CI 7.9%-9.7%), respectively; cross-reactivity was documented with non-Aspergillus pathogens. CONCLUSION: LFA-IMMY is a reliable diagnostic tool for the detection of Aspergillus in respiratory samples.
引用
- Lass-Flörl C, Lo Cascio G, Nucci M, et al. Respiratory specimens and the diagnostic accuracy of Aspergillus lateral flow assays (LFA-IMMY™): real-life data from a multicentre study. Clin Microbiol Infect. 2019. PMID: 31445208. doi:10.1016/j.cmi.2019.08.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。